Moira Hagen

1.3k total citations
22 papers, 1.1k citations indexed

About

Moira Hagen is a scholar working on Epidemiology, Molecular Biology and Genetics. According to data from OpenAlex, Moira Hagen has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Moira Hagen's work include Herpesvirus Infections and Treatments (6 papers), Cytomegalovirus and herpesvirus research (5 papers) and RNA and protein synthesis mechanisms (5 papers). Moira Hagen is often cited by papers focused on Herpesvirus Infections and Treatments (6 papers), Cytomegalovirus and herpesvirus research (5 papers) and RNA and protein synthesis mechanisms (5 papers). Moira Hagen collaborates with scholars based in United States, Sweden and Germany. Moira Hagen's co-authors include Mark Krystal, Thomas D.Y. Chung, Laurence Tiley, James T. Matthews, Christopher Cianci, James West, Brian Terry, Ingrid C. Deckman, Susan M. Majka and Kirk B. Lane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and Journal of Virology.

In The Last Decade

Moira Hagen

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moira Hagen United States 17 469 448 203 177 147 22 1.1k
Scott D. Seiwert United States 19 1000 2.1× 799 1.8× 271 1.3× 123 0.7× 227 1.5× 47 1.7k
Eva Riveira‐Muñoz Spain 22 558 1.2× 195 0.4× 127 0.6× 319 1.8× 49 0.3× 53 1.3k
Kazuoki Osumi Japan 16 224 0.5× 311 0.7× 52 0.3× 197 1.1× 39 0.3× 22 890
Robert C. Sawyer United States 19 714 1.5× 156 0.3× 126 0.6× 171 1.0× 38 0.3× 34 1.3k
Marina Parry United Kingdom 16 382 0.8× 104 0.2× 87 0.4× 58 0.3× 59 0.4× 34 1.0k
R. Graham Smith United States 25 574 1.2× 151 0.3× 40 0.2× 134 0.8× 60 0.4× 48 1.4k
R.L. Heinrikson United States 11 384 0.8× 95 0.2× 50 0.2× 480 2.7× 34 0.2× 13 1.1k
Bert C. Del Villano United States 13 441 0.9× 226 0.5× 131 0.6× 45 0.3× 36 0.2× 19 1.1k
M.P. Civeira Spain 23 570 1.2× 864 1.9× 18 0.1× 209 1.2× 87 0.6× 51 1.9k
W. H. Kirsten United States 16 535 1.1× 180 0.4× 89 0.4× 118 0.7× 49 0.3× 57 1.2k

Countries citing papers authored by Moira Hagen

Since Specialization
Citations

This map shows the geographic impact of Moira Hagen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moira Hagen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moira Hagen more than expected).

Fields of papers citing papers by Moira Hagen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moira Hagen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moira Hagen. The network helps show where Moira Hagen may publish in the future.

Co-authorship network of co-authors of Moira Hagen

This figure shows the co-authorship network connecting the top 25 collaborators of Moira Hagen. A scholar is included among the top collaborators of Moira Hagen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moira Hagen. Moira Hagen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baar, Annieke C.G. van, Amalia Gastaldelli, Ralph A. DeFronzo, et al.. (2024). Insulin sensitivity and beta cell function after duodenal mucosal resurfacing: an open-label, mechanistic, pilot study. Gastrointestinal Endoscopy. 100(3). 473–480.e1. 10 indexed citations
2.
Merkel, Patricia, et al.. (2016). Using directed evolution to improve hydrogen production in chimeric hydrogenases from Clostridia species. Enzyme and Microbial Technology. 93-94. 132–141. 4 indexed citations
3.
Majka, Susan M., Moira Hagen, Thomas R. Blackwell, et al.. (2011). Physiologic and molecular consequences of endothelial Bmpr2 mutation. Respiratory Research. 12(1). 84–84. 51 indexed citations
4.
White, Tiffany, Moira Hagen, Ivy Gudza, et al.. (2008). Genetic diversity of the Kaposi's sarcoma herpesvirus K1 protein in AIDS-KS in Zimbabwe. Journal of Clinical Virology. 42(2). 165–171. 16 indexed citations
5.
Hagen, Moira, Karen Fagan, Wolfgang Steudel, et al.. (2007). Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. American Journal of Physiology-Lung Cellular and Molecular Physiology. 292(6). L1473–L1479. 129 indexed citations
6.
Case, David, David Irwin, Julie W. Harral, et al.. (2006). Mice deficient in galectin-1 exhibit attenuated physiological responses to chronic hypoxia-induced pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology. 292(1). L154–L164. 35 indexed citations
7.
Majka, Susan M., Michelle Beutz, Moira Hagen, et al.. (2005). Identification of Novel Resident Pulmonary Stem Cells: Form and Function of the Lung Side Population. Stem Cells. 23(8). 1073–1081. 71 indexed citations
8.
Hagen, Moira. (2003). A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrology Dialysis Transplantation. 18(10). 2154–2159. 97 indexed citations
9.
Hagen, Moira & Thomas R. Cech. (1999). Self-splicing of the Tetrahymena intron from mRNA in mammalian cells. The EMBO Journal. 18(22). 6491–6500. 34 indexed citations
10.
Cianci, Christopher, Thomas D.Y. Chung, Nicholas A. Meanwell, et al.. (1996). Identification of N-Hydroxamic Acid and N-Hydroxyimide Compounds that Inhibit the Influenza Virus Polymerase. Antiviral chemistry & chemotherapy. 7(6). 353–360. 56 indexed citations
11.
Hagen, Moira, Laurence Tiley, Thomas D.Y. Chung, & Mark Krystal. (1995). The role of template-primer interactions in cleavage and initiation by the influenza virus polymerase. Journal of General Virology. 76(3). 603–611. 31 indexed citations
12.
Tiley, Laurence, Moira Hagen, James T. Matthews, & Mark Krystal. (1994). Sequence-specific binding of the influenza virus RNA polymerase to sequences located at the 5' ends of the viral RNAs. Journal of Virology. 68(8). 5108–5116. 151 indexed citations
13.
Chung, Thomas D.Y., Christopher Cianci, Moira Hagen, et al.. (1994). Biochemical studies on capped RNA primers identify a class of oligonucleotide inhibitors of the influenza virus RNA polymerase.. Proceedings of the National Academy of Sciences. 91(6). 2372–2376. 46 indexed citations
14.
Deckman, Ingrid C., Moira Hagen, & P.J. McCann. (1992). Herpes simplex virus type 1 protease expressed in Escherichia coli exhibits autoprocessing and specific cleavage of the ICP35 assembly protein. Journal of Virology. 66(12). 7362–7367. 53 indexed citations
15.
Bisacchi, Gregory S., Christopher Cianci, Junius M. Clark, et al.. (1991). Synthesis and antiviral activity of enantiomeric forms of cyclobutyl nucleoside analogs. Journal of Medicinal Chemistry. 34(4). 1415–1421. 79 indexed citations
16.
Stevens, John T., M L Haffey, Brian Terry, et al.. (1991). Sensitivity of mutated herpes simplex virus type-1 DNA polymerase to conventional guanine and novel cyclobutane guanine nucleotide analogues. Antiviral Research. 15. 109–109. 1 indexed citations
17.
Yamanaka, Gregory, Anne V. Tuomari, Moira Hagen, et al.. (1991). Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.. Molecular Pharmacology. 40(3). 446–453. 17 indexed citations
18.
Terry, Brian, Christopher Cianci, & Moira Hagen. (1991). Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine.. PubMed. 40(4). 591–6. 21 indexed citations
19.
Field, Anjalie, Anne V. Tuomari, Brian Terry, et al.. (1990). (±)-(1α,2β,3α)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine [(±)-BHCG or SQ 33 054]: A potent and selective inhibitor of herpesviruses. Antiviral Research. 13(1). 41–52. 44 indexed citations
20.
Terry, Brian, Kathryn Mazina, Anne V. Tuomari, et al.. (1988). Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG. Antiviral Research. 10(4-5). 235–251. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott D. Seiwert Breakdown of academic impact, for papers by Eva Riveira‐Muñoz Breakdown of academic impact, for papers by Kazuoki Osumi Breakdown of academic impact, for papers by Robert C. Sawyer Breakdown of academic impact, for papers by Marina Parry Breakdown of academic impact, for papers by R. Graham Smith Breakdown of academic impact, for papers by R.L. Heinrikson Breakdown of academic impact, for papers by Bert C. Del Villano Breakdown of academic impact, for papers by M.P. Civeira Breakdown of academic impact, for papers by W. H. Kirsten
Rankless by CCL
2026